CN106620721B - 单核细胞趋化蛋白-1诱导蛋白1(Mcpip1)在肝缺血再灌注损伤中的应用 - Google Patents
单核细胞趋化蛋白-1诱导蛋白1(Mcpip1)在肝缺血再灌注损伤中的应用 Download PDFInfo
- Publication number
- CN106620721B CN106620721B CN201610873014.3A CN201610873014A CN106620721B CN 106620721 B CN106620721 B CN 106620721B CN 201610873014 A CN201610873014 A CN 201610873014A CN 106620721 B CN106620721 B CN 106620721B
- Authority
- CN
- China
- Prior art keywords
- mcpip1
- liver
- reperfusion injury
- ischemia
- mice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/52—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving transaminase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Abstract
Description
引物名称 | 引物序列 | 酶切位点 |
Mcpip1 LA-F | CCG<u>CTCGAG</u>CTTCTGGTTTTGCTTGCTGA | XhoI |
Mcpip1 LA-R | ATG<u>GACGTC</u>GAGGGGGAGGGTCGGGCCATTTGCAAC | AatII |
Mcpip1 M-F | TCT<u>ACCGGT</u>TACGTGGGGAGCCAGTGT | AgeI |
Mcpip1 M-R | CCG<u>GAATTC</u>TTAGGGCCAAGCCCTTTACC | EcoRI |
Mcpip1 RA-F | CG<u>ACGCGT</u>GTTACTCAGGTAAGGGCTTCAAG | MluI |
Mcpip1 RA-R | ATAAGAAT<u>GCGGCCGC</u>AGAGAGCCACCTAGGAACGA | NotI |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610873014.3A CN106620721B (zh) | 2016-09-30 | 2016-09-30 | 单核细胞趋化蛋白-1诱导蛋白1(Mcpip1)在肝缺血再灌注损伤中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610873014.3A CN106620721B (zh) | 2016-09-30 | 2016-09-30 | 单核细胞趋化蛋白-1诱导蛋白1(Mcpip1)在肝缺血再灌注损伤中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106620721A CN106620721A (zh) | 2017-05-10 |
CN106620721B true CN106620721B (zh) | 2020-05-26 |
Family
ID=58853461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610873014.3A Active CN106620721B (zh) | 2016-09-30 | 2016-09-30 | 单核细胞趋化蛋白-1诱导蛋白1(Mcpip1)在肝缺血再灌注损伤中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106620721B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110124015B (zh) * | 2019-05-25 | 2023-04-07 | 广西医科大学第一附属医院 | 一种胸腺基质淋巴细胞生成素的应用 |
CN113117081A (zh) * | 2019-12-30 | 2021-07-16 | 上海海洋大学 | ZC3H12b基因或蛋白的用途及一种肝脏疾病动物模型的建立方法 |
CN113151178B (zh) * | 2020-01-07 | 2022-09-09 | 清华大学 | 敲除Rc3h1基因和/或Zc3h12a基因的重组T细胞及其应用 |
WO2022147759A1 (en) * | 2021-01-08 | 2022-07-14 | Susheng Biotech (Hainan) Co., Ltd. | Grna molecule targeting intron i or intron ii of hbb gene, synthetic method thereof, and method to correct types of hbb gene mutations |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2758923T3 (es) * | 2011-12-12 | 2020-05-07 | Vascular Biogenics Ltd | Tratamiento de esteatohepatitis no alcohólica |
WO2014020608A1 (en) * | 2012-07-31 | 2014-02-06 | Yeda Research And Development Co. Ltd. | Methods of diagnosing and treating motor neuron diseases |
-
2016
- 2016-09-30 CN CN201610873014.3A patent/CN106620721B/zh active Active
Non-Patent Citations (5)
Title |
---|
MCP-induced protein 1 mediates the minocycline-induced neuroprotection against cerebral ischemia/reperfusion injury in vitro and in vivo;Zhuqing Jin et al.;《Journal of Neuroinflammation》;20150227;第12卷;第1-12页 * |
Monocyte Chemoattractant Protein-Induced Protein 1 Targets Hypoxia-Inducible Factor 1α to Protect Injury;Peng Sun et al.;《Hepatology》;20180509;第68卷(第6期);第2362-2379页 * |
Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines;Jian Liang et al.;《Journal of Neuroinflammation》;20111224;第8卷;摘要,结论 * |
The Role of MCPIP1 in Ischemia/Reperfusion Injury-Induced HUVEC Migration and Apoptosis;Tiebing Zhu et al.;《Cell Physiol Biochem 》;20150901;第37卷;第577-591页 * |
单核细胞趋化蛋白1诱导蛋白与脑缺血;黄少飞 等.;《国际脑血管病杂志》;20150331;第23卷(第3期);摘要 * |
Also Published As
Publication number | Publication date |
---|---|
CN106620721A (zh) | 2017-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106620721B (zh) | 单核细胞趋化蛋白-1诱导蛋白1(Mcpip1)在肝缺血再灌注损伤中的应用 | |
CN104450602B (zh) | 非人哺乳动物神经精神疾病动物模型及其制备方法和用途 | |
CN105112448B (zh) | Stch基因敲除动物模型的构建方法及应用 | |
JPH09500534A (ja) | トランスジェニック動物でのヒトインターロイキン―1βの発現 | |
CN110771573B (zh) | PirB基因敲入的小鼠动物模型及其构建方法 | |
CN110100788B (zh) | 基于基因操作策略构建疾病模型的方法和应用 | |
KR20160012735A (ko) | Dyrk1aa 유전자가 결실된 제브라피쉬 모델 및 이를 이용한 혈관 발생 결함 예방 및 치료제 스크리닝 방법 | |
JP2009502143A (ja) | 雑種強勢又は雑種衰弱を促進する遺伝子とその産生物の同定とその応用 | |
CN113957074B (zh) | 一种小脑共济失调疾病模型的构建方法及应用 | |
Behrens et al. | Comparative analysis of Pax-6 sequence and expression in the eye development of the blind cave fish Astyanax fasciatus and its epigean conspecific. | |
KR100958291B1 (ko) | T―타입 칼슘채널을 억제하여 불안 장애를 치료하는 방법 | |
CN106310225B (zh) | 胱天蛋白酶募集域蛋白6(Card6)在肝缺血再灌注损伤中的应用 | |
JP2009100780A (ja) | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 | |
CN108866069B (zh) | 猪β-防御素2基因在抗猪流感中的应用 | |
JP2023072043A (ja) | 脳障害の治療用材料、脳障害の治療方法、脳の神経細胞の再生用材料、及び、脳の神経細胞の再生方法 | |
CN101570763A (zh) | 一种用于制备人类疾病动物模型的转基因猪及其培育方法 | |
CN110551691A (zh) | 一种特发性基底节钙化致病基因突变小鼠模型的构建 | |
CN115478105B (zh) | Sirt4在肝缺血疾病治疗中的应用 | |
CN115029346B (zh) | 用于靶向敲降Htra2转录本的sgRNA、CRISPR/CasRx系统及应用 | |
CN106421815B (zh) | 双特异性磷酸酶14(Dusp14)在肝缺血再灌注损伤中的应用 | |
CN106620722A (zh) | TNF受体相关因子5(Traf5)在肝缺血再灌注损伤中的应用 | |
CN114868707B (zh) | 一种代谢性脑病和心律失常疾病的斑马鱼模型及其应用 | |
EP0851936A1 (en) | Method of transgene expression and secretion in schistosoma | |
CN108795935B (zh) | 日本血吸虫SjELAV-like 1基因的siRNA及其应用 | |
WO2021098613A1 (zh) | 一种新的小胶质细胞激活方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20191126 Address after: 430040 No.1, floor 1, No.17, eleven village, Changqing Garden, Dongxihu District, Wuhan City, Hubei Province (18) Applicant after: Wuhan Dafeng Biotechnology Co., Ltd Address before: 430072 Hubei Province, Wuhan city Wuchang District of Wuhan University Luojiashan Applicant before: WuHan University |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200603 Address after: 430014 3119, floor 3, building 9, Guanggu science and technology port, 18 huashiyuan North Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee after: Wuhan linyijia Gene Technology Co.,Ltd. Address before: 430040 No.1, floor 1, No.17, eleven village, Changqing Garden, Dongxihu District, Wuhan City, Hubei Province (18) Patentee before: Wuhan Dafeng Biotechnology Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 430076 room 002, 16 / F, building D2, phase III, software new town, No. 8, Huacheng Avenue, Wuhan East Lake New Technology Development Zone, Wuhan, Hubei Province Patentee after: Wuhan Huikang Gene Technology Co.,Ltd. Address before: Room 3119, 3 / F, building 9, Guanggu science and technology harbor, 18 huashiyuan North Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430014 Patentee before: Wuhan linyijia Gene Technology Co.,Ltd. |